Session Details

Cardiac amyloidosis
29 Aug 15:35 - 16:25 Cardiomyopathies Moderated Posters Moderated poster station - Poster Area
Chairpersons: Michael ARAD (Ramat Gan, Israel)
Learning Objectives: Moderated Posters are on display from 14:00 to 18:00 on the plasma screen of the topic related Moderated Poster station. During the moderated poster session (15:35-16:25), from a large plasma screen, Presenters will summarise their research within 3 minutes and then address questions from the Chairpersons and Audience.

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
15:35P5842Comparison of various non-invasive tools for diagnosing AL cardiac amyloidosis.Martin NICOL (Paris, France)
15:35P5843Investigation of left ventricular function and biomarkers following treatment in patients with light-chain cardiac amyloidosis 
15:35P5844Predictors of progression of light-chain cardiac amyloidosis.Vilen RAMEEV (Moscow, Russian Federation)
15:35P5845Prognosis of patients with cardiac amyloidosis referred in the French cardiac amyloidosis expert center.Thibaud DAMY (Creteil, France)
15:35P5846AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathyMamoun ALHAMADSHEH (Stockton, United States of America)
15:35P5847Long-term evolution of longitudinal myocardial deformation in the natural history of familial amyloid polyneuropathyGustavo LIMA DA SILVA (Lisbon, Portugal)
15:35P5848Different features of cardiac involvement in patients with AL vs. TTR amyloidosisVladyslav CHUBUCHNYY (Pisa, Italy)